Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Perjeta, Polivy, Tecentriq, and Phesgo; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept for immunosuppressant; Edirol, an osteoporosis agent; Enspryng, a pH-dependent binding human...
Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 81 3 3281 6611
Fax: 81 3 3281 6607
Address:
Nihonbashi Mitsui Tower, Reception12F 1-1 Nihonbashi-Muromachi 2-chome, Chuo, Japan
